CARS1 and neoplasm: At present, tumor-targeting LNPs carrying various cargoes, such as tumor antigens, CRISPR-Cas9, chimeric antigen receptors (CARs), T-cell receptors (TCRs), and cytokine mRNAs, have been reported5–10.